C ervical spondylotic myelopathy (CSM) is a progressive, degenerative disease that results in compression of the cervical spinal cord, leading to neurological dysfunction. 1 , 2 CSM is the commonest cause of spinal cord impairment in elderly patients worldwide, 1, 2 and yet many controversies exist regarding the optimal management and the outcomes of surgical treatment. Although a number of studies have shown improved neurological outcomes in patients with severe neurological defi cits who receive surgical treatment, 3 -6 the effects of surgery on the full spectrum of CSM cases, ranging from mild to severe, remains in question. Moreover, the relative effi cacy of anterior versus posterior approaches to treat CSM remains hotly debated. Several studies have addressed the uncertainty of anterior versus posterior surgical decompression in CSM Results. One hundred and sixty-nine patients were treated anteriorly and 95 underwent posterior surgery. Anterior surgical cases were younger and had less severe myelopathy as assessed by mJOA and Nurick scores. There were no baseline differences in Neck Disability Index or SF-36 between the anterior and posterior cases. Improvement in the mJOA was signifi cantly lower in the anterior group than posterior group (2.47 vs . 3.62, respectively, P < 0.01), although the groups started at different levels of baseline impairment. The extent of improvement in the Nurick Scale, Neck Disability Index, SF-36 version 2 Physical Component Score, and SF-36 version 2 Mental Component Score did not differ between the groups. Conclusion. Patients with CSM show signifi cant improvements in several health-related outcome measures with either anterior or posterior surgery. Importantly, patients treated with anterior techniques were younger, with less severe impairment and more focal pathology. We demonstrate for the fi rst time that, when patient and disease factors are controlled for, anterior and posterior surgical techniques have equivalent effi cacy in the treatment of CSM.
with the balance of this literature yielding variable yet similar functional outcomes in both cohorts. 6 , 7 , 8 These studies have their key limitations including inadequate follow-up, 6 unvalidated outcome measures, 7 or retrospective analysis. 8 As such, there remains a lack of high-quality evidence guiding surgical management of cervical degenerative myelopathy. This is due to the absence of large, prospective studies using consistent and validated outcome measures supporting any single surgical technique's superiority over another.
In this prospective, controlled multicenter study of patients with mild, moderate, and severe CSM we critically examine the overall effi cacy of surgical treatment and particularly focus on the results of anterior and posterior surgical techniques. We present novel data that show for the fi rst time the dramatic effi cacy of surgery for patients with the full spectrum of CSM. Moreover, we demonstrate that, when patient and disease factors are controlled for, anterior and posterior surgical techniques have equivalent effi cacy in the treatment of CSM.
MATERIALS AND METHODS

Subjects
Two hundred and seventy-eight symptomatic patients with clinically and radiographically confi rmed CSM were enrolled in a multicenter prospective study at 12 sites in North America between December 2005 and September 2007. The study was ethically approved by institutional review boards at all sites and was registered at clinicaltrials.gov (NCT00285337). Subjects were 18 years or older, had symptomatic CSM confi rmed by MRI imaging, had no prior cervical spine surgery, and did not have symptomatic lumbar stenosis. Subjects were treated by either an anterior or posterior decompressive/ reconstructive approach at the discretion of the operative teams. In this article, we report on 264 subjects who have received either anterior or posterior surgery in isolation. Fourteen subjects who received circumferential anterior-posterior surgery were excluded.
Outcome Assessments
Outcome evaluations included the modifi ed Japanese Orthopaedic Association score (mJOA), 6 the Nurick score, 9 the Neck Disability Index (NDI), 10 the Short Form-36 (SF-36) version 2, 11 and an assessment of treatment complications. Subjects were classifi ed as having mild (mJOA > 15), moderate (mJOA, [12] [13] [14] or severe CSM (mJOA < 12) based on the mJOA scores at baseline. However, in this article, patients with the full spectrum of myelopathic impairment were grouped to simplify the data presentation. The SF-36 version 2 Physical Component Score (PCS) and the Mental Component Score (MCS) were calculated using established norms and orthogonal transformations. Adverse events were prospectively tracked using independent assessors with thirdparty data monitoring.
Statistical Analysis
The study endpoints were the absolute changes between the preoperative and 12-month postoperative scores in the various outcome measures described in the earlier text. Missing data were imputed using the multiple imputation method. 12 , 13 Of note, this is the method suggested by the Food and Drug Administration for handling missing data in therapeutic trials.
14 Using the imputed datasets, a t test-like approach was used to compare patient outcomes at 1 year postoperatively with patient status preoperatively. An analysis of differences between the groups was performed using a t test-like approach on multiple imputed samples. This was followed by adjusted multivariate analyses to account for key differences in baseline predictive variables (determined by multiple linear regression techniques). All statistical analyses were performed using SAS version 9.2 (SAS Institute Inc, Cary, NC).
RESULTS
Of the 264 subjects, 169 patients were treated using anterior techniques (discectomy/corpectomy with instrumented fusion) and 95 underwent posterior surgery (either laminectomy and fusion: 86% or laminoplasty: 14%). One subject died at 12 months after surgery of unrelated causes. Eighteen subjects withdrew from the study prior to the 12-month follow-up. Twelve-month follow-up was obtained in 214 (87.0%) out of 246 eligible subjects. Fourteen patients underwent combined anterior and posterior approaches, generally for fi xed kyphotic deformity or complex pathology, and were excluded from analysis. An additional 22 patients did not meet the inclusion criteria of a preoperative mJOA score within the range of 7 to 16.
The key demographic, clinical, and outcome baseline parameters in the study group are summarized in Table 1 and subdivided by the route of surgical approach. Of note, it is clear that clinicians selected different groups of patients for anterior and posterior surgery. Subjects in the anterior group were younger and had more focal cervical pathology, less neurological impairment (with better baseline mJOA and Nurick scores), and better SF-36 version 2 MCS scores. Table 2 summarizes the unadjusted analysis of changes in the outcomes parameters between baseline and 12-month follow-up for the anterior and posterior groups. The 95% confi dence intervals around the mean change scores show that all outcome variables improved signifi cantly from their baseline values in patients treated by either anterior or posterior methods. The extent of improvement in the mJOA was signifi cantly lower in the anterior group than that in patients undergoing posterior surgery (2.47 vs . 3.62, respectively, P < 0.01), although as indicated in Table 1 , the groups started at different levels of baseline impairment. The extent of improvement in the Nurick score, NDI, SF-36 version 2 PCS score, and SF-36 version 2 MCS score did not differ between the anterior and the posterior groups. Table 3 summarizes the analysis of the changes (between baseline and 12-month follow-up) in the outcomes parameters between the anterior and posterior groups with adjustment for baseline confounders. In the adjusted analysis, all outcomes assessments continued to be signifi cantly improved in both the anterior and posterior groups (as refl ected by the change scores and 95% confi dence intervals). Of note, and in contrast to the unadjusted analysis presented in Table 2 , with adjustment for baseline confounders, there were no significant differences in outcomes between patients treated with the anterior and posterior surgical approaches.
The anterior-and posterior-only groups did not differ signifi cantly with regard to the overall complication rates. Twenty patients (11.8%) in the anterior and 17 patients (17.9%) in the posterior group had treatment-related complication ( P = 0.197). Seven subjects (4.1%) in the anterior and 3 (3.2%) in the posterior group experienced a new neurological defi cit ( P = 1.00). There were 5 transient postoperative C5 palsies, which occurred in association with both posterior-and anterior-only procedures, and there was no significant difference in the rates based on surgical approach. Three other transient nerve root defi cits occurred, as well as 2 cases of deterioration in spinal cord function (0.8%). Of the 2 cases of spinal cord deterioration, 1 occurred in the anterior group and 1 in the posterior group.
There were 5 superfi cial infections in total: 1 in the anterior group and 4 in the posterior group ( P = 0.058). The remaining complications (n = 22) comprised a heterogenous group of adverse events including cardiopulmonary complications such as myocardial infarction and pulmonary embolus, instrumentation malposition/migration, durotomy, epidural hematoma, renal complications, altered mental status, worsened axial neck pain, dysphonia, wound dehiscence, symptomatic adjacent segment disease, and symptomatic pseudoarthrosis. All occurred sporadically and with no signifi cant difference between the 2 groups.
DISCUSSION
This prospective observational multicenter study of 264 patients demonstrates novel data that when patient and disease factors are controlled for, anterior and posterior surgical approaches have equivalent effi cacy in the treatment of CSM. Despite being the most common cause of acquired neurological disability in those older than 50 2 years, there remains a lack of high-quality evidence guiding surgical management of cervical degenerative myelopathy. This is due to the absence of large, prospective studies using consistent and validated outcome measures to support any single surgical approach compared with another. The lack of high-level evidence is compounded by the diversity of both the patient population and the surgical modalities with which they are treated. This methodological heterogeneity also makes interstudy evaluation of the literature diffi cult to interpret. Expert opinion and general consensus support the notion that any modality that effectively decompresses the affected segments of spinal cord and nerve roots are equally effi cacious in the short term.
Options include posterior approaches in the form of laminectomy, laminectomy plus instrumented arthrodesis, or laminoplasty ( Figure 1A, B ) . Anterior approaches include anterior cervical discectomy or corpectomy and fusion ( Figure 2A, B ) . A third category encompasses circumferential decompression with both anterior and posterior reconstructive techniques using combinations of the above-mentioned approaches. The surgical strategy elected is dependent upon multiple factors, most importantly the cause of compression, the primary site of compression, the number of levels involved and the sagittal alignment of the spine. Patient age, general medical status, and comorbidities are also important considerations.
Last but not the least, the surgeon's familiarity and comfort level with each technique must be considered. Although there are no absolute indications for any given approach, some guiding principles are generally followed. These include approaching the cervical spine anteriorly when the primary site of compression is ventral, and vice versa . Anterior approaches are usually reserved for compression at 3 levels or less; however, this is not always the case ( Figure 3 ). Anterior approaches are generally preferred when restoration of cervical lordosis is a primary surgical goal. Taking these factors into account, a single optimal surgical approach can usually be chosen. Whether or not the specifi c approach is taken, be it anterior or posterior, results in disparate outcomes are addressed in this study.
After surgical decompression, symptoms of patients with CSM, including those of patients with the full spectrum of impairment ranging from mild to severe neurological dysfunction, improved signifi cantly in all evaluated endpoints, including neurological (mJOA and Nurick scores), functional (NDI), and generic (SF-36 version 2) health outcome measures. This is in contrast to the only prospective randomized trial to date in CSM, which failed to detect a benefi cial effect of surgery, but was limited by a single-center design, small enrollment and the use of nonvalidated outcomes. 15 Importantly, the baseline differences between the anterior and posterior groups were signifi cant and impacted on the outcomes. In particular, surgeons chose anterior techniques to treat patients who were younger and who presented with less impairment and more focal cervical pathology. On the unadjusted analyses, patients treated with posterior surgical methods had higher apparent improvement in mJOA scores and those treated with anterior techniques had superior outcomes based on SF-36 PCS scores. However, with adjustment for key baseline covariates, there were no differences in the outcomes between the groups treated with anterior or posterior surgical techniques. Moreover, major complications were similar in the 2 groups, although there was a trend for a higher infection rate with posterior surgical techniques.
The key limitation of our study design is the lack of randomization. However, the investigators in SpineNet (AOSpine Clinical Research Network) thought that randomization to nonoperative versus operative management or that based on the choice of surgical technique would be ethically and logistically very challenging. In most cases, surgeons do not perceive equipoise between anterior and posterior techniques, although admittedly some cases can be treated by either methodology. It was very apparent that patient variables and the nature of the pathology were prime drivers in surgical decision making. Patients with more focal pathology underwent anterior surgery and conversely, those with multilevel cervical involvement usually were treated by posterior techniques. Indeed, the literature supports the selective application of anterior and posterior techniques based on these considerations. 3 -6 In our view, the design of our study, despite the limitations imposed by the lack of randomization was successful in addressing the key questions that were posed on the basis of the high level of prospective enrollment of consecutive cases, the use of multiple outcome measures and the excellent follow-up (87% at 1 yr). Of note, the only randomized trial to date, which failed to show a benefi cial effect of surgery for CSM, had several serious fl aws including limitation of the assessments to only 1 nonvalidated outcome measure and low enrollment at a single center. 15 This study may be viewed by some as largely a demonstration of surgeon's trends and preferences regarding the management of cervical degenerative myelopathy. Despite the lack of randomization, it is the authors opinion that this limitation can be looked upon favorably as it represents as close to a "realworld" consecutive series of patients as possible. In reality, only a small subset of patients would truly be eligible for randomization. These would include patients with a straight or lordotic spine who had compressive pathology at 3 levels or less.
We applied advanced multivariate techniques to adjust for potential confounders between the anterior and the posterior group. Moreover, rather than excluding subjects who were lost to follow-up, we used multiple imputation statistical techniques to re-create the complete sample. 16 However, we acknowledge that there may still be a window to consider a randomized prospective trial of anterior versus posterior surgery for selected patients with CSM where there is true equipoise between surgical strategies.
CONCLUSION
The results from this large, prospective multicenter study validate the relative equivalence between anterior and posterior treatment for CSM that many spine surgeons think exists. This study demonstrates for the fi rst time that anterior and posterior surgery, when the treatment choice is left to surgeon, experience signifi cant, and similar improvements with regard to neurological, functional, and quality-of-life outcomes with comparable and very low rates of neurological complication.
➢ Key Points
CSM is the commonest cause of spinal cord impairment in elderly patients worldwide, yet the relative effi cacy of anterior versus posterior approaches to treat CSM remains a matter of debate. The results from this large, prospective multicenter study support the idea of relative equivalence between anterior and posterior surgery for CSM that many spine surgeons think exists. Patients treated with anterior techniques (n = 169) were younger, had less severe neurological impairment, and more focal pathology than those treated with posterior approaches (n = 95). This study demonstrates for the fi rst time that anterior and posterior surgery, when the treatment choice is left to surgeon, have equivalent effi cacy in the treatment of CSM.
